CoChat

Apoptotic effects of antilymphocyte globulins on human pro-inflammatory CD4+CD28- T-cells

Open access

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Pro-inflammatory, cytotoxic CD4(+)CD28(-) T-cells with known defects in apoptosis have been investigated as markers of premature immuno-senescence in various immune-mediated diseases. In this study we evaluated the influence of polyclonal antilymphocyte globulins (ATG-Fresenius, ATG-F) on CD4(+)CD28(-) T-cells in vivo and in vitro. PRINCIPAL FINDINGS: Surface and intracellular three colour fluorescence activated cell sorting analyses of peripheral blood mononuclear cells from 16 consecutive transplant recipients and short-term cell lines were performed. In vivo, peripheral levels of CD3(+)CD4(+)CD28(-) T-cells decreased from 3.7 ± 7.1% before to 0 ± 0% six hours after ATG-F application (P = 0.043) in 5 ATG-F treated but not in 11 control patients (2.9 ± 2.9% vs. 3.9 ± 3.0%). In vitro, ATG-F induced apoptosis even in CD4(+)CD28(-) T-cells, which was 4.3-times higher than in CD4(+)CD28(+) T-cells. ATG-F evoked apoptosis was partially reversed by the broad-spectrum caspase inhibitor benzyloxycarbonyl (Cbz)-Val-Ala-Asp(OMe)-fluoromethylketone (zVAD-fmk) and prednisolon-21-hydrogensuccinate. ATG-F triggered CD25 expression and production of pro-inflammatory cytokines, and induced down-regulation of the type 1 chemokine receptors CXCR-3, CCR-5, CX3CR-1 and the central memory adhesion molecule CD62L predominately in CD4(+)CD28(-) T-cells. CONCLUSION: In summary, in vivo depletion of peripheral CD3(+)CD4(+)CD28(-) T-cells by ATG-F in transplant recipients was paralleled in vitro by ATG-F induced apoptosis. CD25 expression and chemokine receptor down-regulation in CD4(+)CD28(-) T-cells only partly explain the underlying mechanism.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0033939

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Treatment with polyclonal antilymphocyte globulins induces depletion of circulating CD3+CD4+CD28− T-cells in transplant recipients. Prevalences of peripheral circulating CD3+CD4+CD28− T-cells in 16 age- and sex-matched healthy controls, 5 allograft recipients before and 6 hours after the application of ATG-F and 11 control patients before and 6 hours after organ transplantation. Data are given as mean±standard error of the mean (SEM).
Figure 1 Treatment with polyclonal antilymphocyte globulins induces depletion of circulating CD3+CD4+CD28− T-cells in transplant recipients. Prevalences of peripheral circulating CD3+CD4+CD28− T-cells in 16 age- and sex-matched healthy controls, 5 allograft recipients before and 6 hours after the application of ATG-F and 11 control patients before and 6 hours after organ transplantation. Data are given as mean±standard error of the mean (SEM).CC BY · PubMed Central
Figure 2 Antilymphocyte globulins preferentially trigger apoptosis in CD4+CD28− T-cell subsets in vitro. ( A ) Influence of different doses of ATG-F on the prevalence of CD3+CD4+CD28− T-cells in one representative patient. ATG-F or rabbit IgG (rIgG) were applied for 18 hours, as indicated. ( B ) Representative histograms showing ATG-F induced apoptosis measured by AnnexinV staining in various doses in comparison to unspecific rabbit IgG by three colour FACS analysis. Gates were set on lymphocytes (forward and sideward scatter) as well as on CD4+CD28+ and CD4+CD28− cells (not shown), and markers according to the negative control. ATG-F induced apoptosis in both, CD28+ and CD28−CD4+ T-cell subsets in a dose- (n = 6) ( C ) and time dependent manner (30 µg/ml ATG-F, n = 6) ( D ) measured by AnnexinV staining in flow cytometry. Data are given as mean (bars) and standard deviation (lines) for CD4+CD28+ (white) and CD4+CD28− T-cells (grey). To account for the different rate of apoptosis in unstimulated CD28+ and CD28−CD4+ T-cells, AnnexinV+ cells are depicted as the ratio of ATG-F versus rabbit IgG stimulated cells. An asterisk indicates significant differences (P<0.05) between CD28+ and CD28−CD4+ T-cell subsets. Significances between rabbit IgG and ATG-F evoked apoptosis were found at doses of 30–300 µg/ml ATG-F in CD4+CD28+ and at doses of 3–300 µg/ml ATG-F in CD4+CD28− T-cells (each with P<0.05). In the time course the ATG-F triggered effect on apoptosis was first detectable after 2 hours in both CD4+ T-cell subsets (each with P<0.05).
Figure 2 Antilymphocyte globulins preferentially trigger apoptosis in CD4+CD28− T-cell subsets in vitro. ( A ) Influence of different doses of ATG-F on the prevalence of CD3+CD4+CD28− T-cells in one representative patient. ATG-F or rabbit IgG (rIgG) were applied for 18 hours, as indicated. ( B ) Representative histograms showing ATG-F induced apoptosis measured by AnnexinV staining in various doses in comparison to unspecific rabbit IgG by three colour FACS analysis. Gates were set on lymphocytes (forward and sideward scatter) as well as on CD4+CD28+ and CD4+CD28− cells (not shown), and markers according to the negative control. ATG-F induced apoptosis in both, CD28+ and CD28−CD4+ T-cell subsets in a dose- (n = 6) ( C ) and time dependent manner (30 µg/ml ATG-F, n = 6) ( D ) measured by AnnexinV staining in flow cytometry. Data are given as mean (bars) and standard deviation (lines) for CD4+CD28+ (white) and CD4+CD28− T-cells (grey). To account for the different rate of apoptosis in unstimulated CD28+ and CD28−CD4+ T-cells, AnnexinV+ cells are depicted as the ratio of ATG-F versus rabbit IgG stimulated cells. An asterisk indicates significant differences (P<0.05) between CD28+ and CD28−CD4+ T-cell subsets. Significances between rabbit IgG and ATG-F evoked apoptosis were found at doses of 30–300 µg/ml ATG-F in CD4+CD28+ and at doses of 3–300 µg/ml ATG-F in CD4+CD28− T-cells (each with P<0.05). In the time course the ATG-F triggered effect on apoptosis was first detectable after 2 hours in both CD4+ T-cell subsets (each with P<0.05).CC BY · PubMed Central
Figure 3 Antilymphocyte globulin-triggered apoptosis of CD4+ T-cells partially depends on activation of caspases. To investigate the underlying mechanisms of apoptosis induction in CD4+ T-cells by ATG-F ( A ) a caspase-mediated mechanism (n = 5) was analysed by AnnexinV staining in flow cytometry. ( B ) As the immunosuppressive agents prednisolon-21-hydrogensuccinate (glucocorticoid), FK506 and cyclosporine A are known to interfere with the interleukin (IL)-2 pathway, their influence on ATG-F mediated apoptosis was examined in CD28+ and CD28−CD4+ T-cell subsets (n = 6). Data are given as mean (bars) and standard deviation (lines) for CD4+CD28+ (white) and CD4+CD28− T-cells (grey). An asterisk indicates significant differences (P<0.05) between CD28+ and CD28−CD4+ T-cell subsets. Depicting significances broken and continuous lines were used for CD28+ and CD28−CD4+ T-cells, respectively.
Figure 3 Antilymphocyte globulin-triggered apoptosis of CD4+ T-cells partially depends on activation of caspases. To investigate the underlying mechanisms of apoptosis induction in CD4+ T-cells by ATG-F ( A ) a caspase-mediated mechanism (n = 5) was analysed by AnnexinV staining in flow cytometry. ( B ) As the immunosuppressive agents prednisolon-21-hydrogensuccinate (glucocorticoid), FK506 and cyclosporine A are known to interfere with the interleukin (IL)-2 pathway, their influence on ATG-F mediated apoptosis was examined in CD28+ and CD28−CD4+ T-cell subsets (n = 6). Data are given as mean (bars) and standard deviation (lines) for CD4+CD28+ (white) and CD4+CD28− T-cells (grey). An asterisk indicates significant differences (P<0.05) between CD28+ and CD28−CD4+ T-cell subsets. Depicting significances broken and continuous lines were used for CD28+ and CD28−CD4+ T-cells, respectively.CC BY · PubMed Central
Figure 4 Down-regulation of Th1 type chemokine and leukocyte homing receptors by antilymphocyte globulins in CD4+CD28− T-cells. Dose dependent in vitro effects of ATG-F on surface expression of the type 1 chemokine receptors ( A ) CCR-5, ( B ) CXCR-3, ( C ) CX3CR-1, the type 2 chemokine receptor ( D ) CCR-4, and the central memory receptors ( E ) CD62L and ( F ) CCR-7 on CD4+ T-cell subsets in comparison to rabbit IgG (rIgG) (n = 6). Data are given as mean (bars) and standard deviation (lines) for CD4+CD28+ (white) and CD4+CD28− T-cells (grey). An asterisk indicates significant differences (P<0.05) between CD28+ and CD28−CD4+ T-cell subsets. Depicting significances between rabbit IgG and ATG-F induced modulation of chemokine receptor expression broken and continuous lines were used for CD28+ and CD28−CD4+ T-cells, respectively.
Figure 4 Down-regulation of Th1 type chemokine and leukocyte homing receptors by antilymphocyte globulins in CD4+CD28− T-cells. Dose dependent in vitro effects of ATG-F on surface expression of the type 1 chemokine receptors ( A ) CCR-5, ( B ) CXCR-3, ( C ) CX3CR-1, the type 2 chemokine receptor ( D ) CCR-4, and the central memory receptors ( E ) CD62L and ( F ) CCR-7 on CD4+ T-cell subsets in comparison to rabbit IgG (rIgG) (n = 6). Data are given as mean (bars) and standard deviation (lines) for CD4+CD28+ (white) and CD4+CD28− T-cells (grey). An asterisk indicates significant differences (P<0.05) between CD28+ and CD28−CD4+ T-cell subsets. Depicting significances between rabbit IgG and ATG-F induced modulation of chemokine receptor expression broken and continuous lines were used for CD28+ and CD28−CD4+ T-cells, respectively.CC BY · PubMed Central
Figure 5 Production of pro-inflammatory cytokines by polyclonal antilymphocyte globulins in CD4+CD28− T-cells. ( A ) To test whether ATG-F treatment leads to cytokine production of CD4+ T-cell subsets in vitro, stimulation with rabbit IgG (rIgG), phorbol 12-myristate 13-acetate (PMA)/ionomycin, and ATG-F at a dose of 300 µg/ml or 1000 µg/ml and intracellular cytokine staining for IFN-γ, TNF-α and IL-4 was performed (n = 6). Whiskers box plots show 50% of cases within the boxes and all data excluding mavericks between the end-points of the whiskers (lines). An asterisk indicates significant differences (P<0.05) between CD28+ and CD28−CD4+ T-cell subsets. Depicting significances between rabbit IgG, PMA/ionomycin and ATG-F induced cytokine expression broken and continuous lines were used for CD28+ and CD28−CD4+ T-cells, respectively. ( B ) Representative dot plot and histograms depicting ATG-F induced production of TNF-α after 4 hours of stimulation in supramitogenic dosages of 300 µg/ml and 1000 µg/ml in comparison to stimulation with unspecific rIgG and PMA/ionomycin in the presence of brefeldin A. Gates were set on lymphocytes (forward and sideward scatter) as well as on CD4+CD28+ and CD4+CD28− cells, and markers according to the negative control.
Figure 5 Production of pro-inflammatory cytokines by polyclonal antilymphocyte globulins in CD4+CD28− T-cells. ( A ) To test whether ATG-F treatment leads to cytokine production of CD4+ T-cell subsets in vitro, stimulation with rabbit IgG (rIgG), phorbol 12-myristate 13-acetate (PMA)/ionomycin, and ATG-F at a dose of 300 µg/ml or 1000 µg/ml and intracellular cytokine staining for IFN-γ, TNF-α and IL-4 was performed (n = 6). Whiskers box plots show 50% of cases within the boxes and all data excluding mavericks between the end-points of the whiskers (lines). An asterisk indicates significant differences (P<0.05) between CD28+ and CD28−CD4+ T-cell subsets. Depicting significances between rabbit IgG, PMA/ionomycin and ATG-F induced cytokine expression broken and continuous lines were used for CD28+ and CD28−CD4+ T-cells, respectively. ( B ) Representative dot plot and histograms depicting ATG-F induced production of TNF-α after 4 hours of stimulation in supramitogenic dosages of 300 µg/ml and 1000 µg/ml in comparison to stimulation with unspecific rIgG and PMA/ionomycin in the presence of brefeldin A. Gates were set on lymphocytes (forward and sideward scatter) as well as on CD4+CD28+ and CD4+CD28− cells, and markers according to the negative control.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 23

Metadata

Authors
Duftner, C., Dejaco, C., Hengster, P., Bijuklic, K., Joannidis, M., Margreiter, R., & Schirmer, M.
Affiliations
  • Innsbruck Medical University (AT)
  • University of Graz (AT)
Corresponding author
Schirmer, Michael
Venue
PLoS ONE
Published
2012-03-30
Volume
7
Issue
3
Pages
e33939
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2056247835
Cited by
23
References
51
Citations by year
2026: 2 · 2025: 2 · 2024: 4 · 2022: 2 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 3 · 2017: 1 · 2016: 2 · 2015: 3
FWCI
0.42
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
  • Fresenius Medical Care North America
  • Karl-Franzens-Universität Graz
  • Medizinische Universität Graz
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Keywords
antilymphocyte globulin, CD4+CD28- T cells, apoptosis, immunosuppression, transplant recipients, CD25 expression, chemokine receptor down-regulation, CXCR3, CCR5, CX3CR1, L-selectin, inflammatory cytokines, caspase inhibition, prednisolone
MeSH terms
Adult, Antilymphocyte Serum, Enzyme Activation, Female, Humans, Immunologic Factors, Inflammation, Interleukin-2, Lymphocyte Depletion, Male, Middle Aged, Signal Transduction, CD4-Positive T-Lymphocytes, Down-Regulation, Cytokines, Organ Transplantation, Apoptosis, CD3 Complex, CD28 Antigens, Th1 Cells, fas Receptor, Receptors, Chemokine, Caspases, Young Adult, Transendothelial and Transepithelial Migration

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.